platinum has been researched along with Proteinuria in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chi, Y; Li, A; Lin, S; Zheng, D | 1 |
Broggini, M; Ilyechova, EY; Puchkova, LV; Rusconi, P; Skvortsov, AN | 1 |
Elferink, F; Henzen-Logmans, SC; Pinedo, HM; Van der Poort, SE; Van der Vijgh, WJ | 1 |
Bertolero, F; Litterst, CL | 1 |
Erdlenbruch, B; Grunewald, RW; Kern, W; Lakomek, M; Pekrum, A; Roth, C | 1 |
Gambling, L; Kingsley, GH; Panayi, GS; Verwilghen, J | 1 |
Hidaka, S; Inoue, T; Kiyozumi, M; Kojima, S; Tsuruoka, M | 1 |
Lelieveld, P; van der Vijgh, WJ; van Velzen, D | 1 |
1 trial(s) available for platinum and Proteinuria
Article | Year |
---|---|
Cisplatin nephrotoxicity in children after continuous 72-h and 3x1-h infusions.
Topics: Adolescent; Antineoplastic Agents; Area Under Curve; Biomarkers; Child; Child, Preschool; Cisplatin; Female; Half-Life; Humans; Infusions, Intravenous; Kidney Diseases; Kidney Glomerulus; Male; Platinum; Proteinuria | 2001 |
7 other study(ies) available for platinum and Proteinuria
Article | Year |
---|---|
Black oxidized 3,3',5,5'-tetramethylbenzidine nanowires (oxTMB NWs) for enhancing Pt nanoparticle-based strip immunosensing.
Topics: Benzidines; Biomarkers; Humans; Immunoassay; Metal Nanoparticles; Nanowires; Oxidation-Reduction; Platinum; Proteinuria | 2019 |
In vivo effect of copper status on cisplatin-induced nephrotoxicity.
Topics: Animals; Antineoplastic Agents; Cisplatin; Copper Sulfate; Injections, Intraperitoneal; Kidney; Male; Mice; Mice, Inbred C57BL; Platinum; Proteinuria; Tissue Distribution | 2016 |
Influence of hydrolysis products of aqua(1,1-bis(aminomethyl)cyclohexane)sulfatoplatinum(II) on toxicity in rats.
Topics: Animals; Body Weight; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Hydrolysis; Kidney; Male; Organoplatinum Compounds; Platinum; Proteinuria; Rats; Rats, Inbred Strains; Solutions | 1984 |
Changes in renal handling of platinum in cisplatinum-treated rats following induction of metabolic acidosis or alkalosis.
Topics: Acid Phosphatase; Acidosis; Alkalosis; Animals; Cisplatin; Female; Hydrogen-Ion Concentration; Kidney; Platinum; Proteinuria; Rats; Rats, Inbred Strains; Time Factors | 1982 |
Activation of gold-reactive T lymphocytes in rheumatoid arthritis patients treated with gold.
Topics: Adult; Aged; Animals; Arthritis, Rheumatoid; Cell Division; Cells, Cultured; Colitis; Copper; Dermatitis; DNA; Female; Gold; Humans; Lymphocyte Activation; Male; Mice; Middle Aged; Nickel; Platinum; Proteinuria; T-Lymphocytes; Thymidine; Tritium | 1992 |
Protection against cis-diamminedichloroplatinum-induced nephrotoxicity in rats by N-benzyl-D-glucamine dithiocarbamate.
Topics: Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weight; Carcinoma 256, Walker; Cisplatin; Female; Glycosuria; Kidney; Liver; Male; Platinum; Proteinuria; Random Allocation; Rats; Rats, Inbred Strains; Sorbitol; Thiocarbamates | 1991 |
Toxicology and pharmacokinetics of (1,1-bis(aminomethyl)cyclohexane)oxalatoplatinum(II) (TNO-38).
Topics: Animals; Antineoplastic Agents; Body Weight; Dogs; Drug Evaluation, Preclinical; Half-Life; Kinetics; Lethal Dose 50; Male; Mice; Organoplatinum Compounds; Platinum; Proteinuria; Rats | 1986 |